Kelly, R. J., Rajan, A., Force, J., Lopez-Chavez, A., Keen, C., Cao, L., . . . Giaccone, G. (2011). Evaluation of KRAS mutations, angiogenic biomarkers and DCE-MRI in patients with advanced non-small cell lung cancer receiving sorafenib.
Stile di citazione ChicagoKelly, Ronan J., et al. Evaluation of KRAS Mutations, Angiogenic Biomarkers and DCE-MRI in Patients With Advanced Non-small Cell Lung Cancer Receiving Sorafenib. 2011.
Citazione MLAKelly, Ronan J., et al. Evaluation of KRAS Mutations, Angiogenic Biomarkers and DCE-MRI in Patients With Advanced Non-small Cell Lung Cancer Receiving Sorafenib. 2011.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.